| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.76 | 0.004 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.006 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.36 | 0.007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |